SCHEMBL26435385

SCHEMBL26435385

c1ccc2c(c1)cc(-c1nc(-c3ccc4sc5ccccc5c4c3)nc(-c3cccc4ccc5ccccc5c34)n1)c1ccccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
HSD17B10 Q99714 3/20 0.35
HPGD P15428 2/20 0.35
HIF1A Q16665 2/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.35
NQO2 P16083 2/20 0.34
NQO1 P15559 1/20 0.34
ALOX5 P09917 1/20 0.34
CYP1A2 P05177 3/20 0.33
ERBB2 P04626 1/20 0.33
FYN P06241 1/20 0.33
MAOA P21397 1/20 0.33
ACHE P22303 1/20 0.33
AHR P35869 1/20 0.33
GPR3 P46089 1/20 0.33
CYP11B1 P15538 1/20 0.32
MAPT P10636 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435703 0.95 L3MBTL1 (0.34) ALDH1A1L3MBTL1HSD17B10HPGDHIF1A
SCHEMBL26435404 0.95 L3MBTL1 (0.34) ALDH1A1L3MBTL1HSD17B10HPGDHIF1A
SCHEMBL26435330 0.93 ALDH1A1 (0.35) ALDH1A1L3MBTL1HSD17B10HPGDHIF1A
SCHEMBL26435375 0.92 ALOX5 (0.36) ALDH1A1L3MBTL1HSD17B10HPGDTSHR
SCHEMBL23283956 0.91 ALDH1A1 (0.37) ALDH1A1L3MBTL1HSD17B10HPGDHIF1A
SCHEMBL26435508 0.90 L3MBTL1 (0.33) ALDH1A1L3MBTL1HSD17B10HPGDHIF1A
SCHEMBL27251257 0.90 S1PR5 (0.35) ALDH1A1L3MBTL1HSD17B10HPGDHIF1A
SCHEMBL24473202 0.90 F9 (0.36) ALDH1A1L3MBTL1HSD17B10HPGDHIF1A
SCHEMBL26435376 0.89 PIM3 (0.37) ALDH1A1L3MBTL1HSD17B10HPGDTSHR
SCHEMBL26435374 0.89 ALDH1A1 (0.34) ALDH1A1L3MBTL1HSD17B10HPGDHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALDH1A1 1532/4885L3MBTL1 1536/4885HSD17B10 4425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.